PIRAMAL PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148 INR | +1.61% |
|
+0.27% | +6.63% |
| 14/05 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
| 13/05 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 235.18Cr | ||||||
| 74TCr | ||||||
| 60TCr | ||||||
| 35TCr | ||||||
| 32TCr | ||||||
| 28TCr |
